ENNUMO
Live / Allowed — Published for opposition (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99806285
- Mark type
- Stylized text
- Filed
- 06 May 2026
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Michele K Robichaux
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of cancer and cancer-related comorbidities; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for stimulating white blood cell production; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer and cancer-related comorbidities
Owner
- Accord Biopharma, Inc., Raleigh, NC, US
- Accord Biopharma, Inc., Raleigh, NC, US
Prosecution history
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 03 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 03 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 25 Jul 2026 — ASSIGNED TO EXAMINER
- 06 May 2026 — APPLICATION FILING RECEIPT MAILED
- 06 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 May 2026 — NEW APPLICATION ENTERED